Effect of Dapagliflozin, Metformin and Physical Activity on Glucose Variability, Body Composition and Cardiovascular Risk in Pre-diabetes
Latest Information Update: 30 Nov 2021
At a glance
- Drugs Dapagliflozin (Primary) ; Metformin
- Indications Prediabetic state; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Pre-D
- 22 Nov 2021 Results of an analysis assessing the process of health behavior changes following participation in a randomised controlled trial targeting prediabetes published in the Diabetic Medicine
- 25 Sep 2020 Results assessing association of dapagliflozin, metformin and exercise with plasma glucagon concentrations in individuals with HbA 1c defined prediabetes presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
- 16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association